Journey Medical (DERM) Capital Expenditures (2020 - 2023)

Journey Medical's Capital Expenditures history runs 3 years deep, the most recent figure standing at $5.0 million for Q1 2023.

• Quarterly Capital Expenditures fell 75.0% year-over-year to $5.0 million in Q1 2023, while the trailing twelve-month figure through Dec 2023 was $5.0 million (down 75.0% YoY) and the FY2024 annual result came in at $15.0 million, up 200.0% from the prior year.
• Capital Expenditures was $5.0 million for Q1 2023 at Journey Medical, down from $20.0 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $20.0 million in Q1 2022 and bottomed at $4.1 million in Q4 2020.
• A 3-year average of $9.7 million and a median of $5.0 million in 2023 frame the typical range for Capital Expenditures.
• Peak annual rise in Capital Expenditures reached 75.0% in 2023, while the deepest fall reached 75.0% in 2023.
• Journey Medical's Capital Expenditures stood at $4.1 million in 2020, then soared by 382.51% to $20.0 million in 2022, then plunged by 75.0% to $5.0 million in 2023.
• Business Quant data shows DERM's Capital Expenditures at $5.0 million in Q1 2023, $20.0 million in Q1 2022, and $4.1 million in Q4 2020.